ORUM THERAPEUTICS, INC. revenue for the last year amounted to 20.90 B KRW, the most of which — 20.91 B KRW — came from its highest performing source at the moment, Medical and Pharmaceutical Research and Development, the year earlier bringing 135.42 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought ORUM THERAPEUTICS, INC. 20.91 B KRW, and the year before that — 135.42 B KRW.